| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,987 |
11,129 |
$787K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,603 |
3,157 |
$278K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,456 |
2,310 |
$168K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,168 |
5,285 |
$165K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,050 |
2,610 |
$72K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
256 |
239 |
$66K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
869 |
810 |
$63K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
751 |
711 |
$60K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
635 |
574 |
$43K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
557 |
475 |
$42K |
| 95117 |
|
5,160 |
1,679 |
$39K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,118 |
2,515 |
$35K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
471 |
454 |
$35K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
397 |
372 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
485 |
432 |
$15K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
124 |
109 |
$14K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
88 |
69 |
$13K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
28 |
27 |
$8K |
| 90686 |
|
516 |
465 |
$5K |
| 87634 |
|
85 |
75 |
$5K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
23 |
20 |
$5K |
| 90670 |
|
364 |
356 |
$4K |
| 90734 |
|
315 |
305 |
$4K |
| 99384 |
|
47 |
44 |
$4K |
| 90651 |
|
252 |
238 |
$3K |
| 90671 |
|
216 |
179 |
$3K |
| 90723 |
|
223 |
217 |
$3K |
| 90620 |
|
183 |
178 |
$2K |
| 90710 |
|
202 |
197 |
$2K |
| 90647 |
|
219 |
214 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
61 |
57 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
28 |
26 |
$2K |
| 87807 |
|
171 |
142 |
$2K |
| 99383 |
|
19 |
19 |
$2K |
| 90715 |
|
149 |
139 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$1K |
| 90633 |
|
134 |
123 |
$1K |
| 90680 |
|
125 |
116 |
$1K |
| 90697 |
|
105 |
80 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
42 |
37 |
$836.85 |
| 36415 |
Collection of venous blood by venipuncture |
363 |
299 |
$745.55 |
| 90656 |
|
66 |
65 |
$745.33 |
| 90696 |
|
69 |
66 |
$704.00 |
| 0001A |
|
18 |
16 |
$608.00 |
| 83655 |
|
31 |
29 |
$290.00 |
| 90700 |
|
13 |
12 |
$132.00 |
| 85018 |
|
20 |
19 |
$40.89 |